Global Efforts to Reduce Tobacco Usage: WHO Report

Regulations by 2FIRSTS.ai
Jan.29.2024
Global Efforts to Reduce Tobacco Usage: WHO Report
WHO report shows global smoking rates have decreased over the past 20 years, but challenges remain, especially in Kazakhstan.

According to a report from the World Health Organization (WHO) on January 28, the latest findings indicate that 150 countries worldwide have successfully reduced tobacco use in the past 20 years. The global smoking rate among adults has decreased from one-third to one-fifth. Brazil and the Netherlands have seen success in lowering smoking rates through implementing these measures, with Latin American countries experiencing a decline of 35% and European countries approaching their target of 30%.

 

According to Zhanar Karmakova, Deputy Chief of the National Public Health Center of the Ministry of Health of Kazakhstan, despite a 9% decrease in smoking rates in Kazakhstan in 2019 compared to 2014, the number of adult smokers in the country is still expected to reach 2.9 million, indicating persistent challenges.

 

According to reports, while smoking rates among men in Kazakhstan are decreasing, rates among women are increasing. The use of nicotine-containing products, including e-cigarettes, has caught the attention of young people. A national survey on the health behaviors of school-age children in Kazakhstan revealed that 9.8% of teenagers have tried e-cigarettes at least once. In order to protect the next generation, the World Health Organization has designated this year's World No Tobacco Day theme as intervention against the tobacco industry targeting children.

 

According to predictions, the European region of the World Health Organization (WHO) is expected to become the highest tobacco-consuming region globally by the year 2030, with the proportion of female smokers reaching twice the global average. In response, the WHO is strongly urging countries to enhance their tobacco control policies and strategies.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.
Sep.09
Thailand's Senate and House of Representatives have different stances on e-cigarettes: the Senate advocates a ban on sales, while the House of Representatives proposes legalization and regulation
Thailand's Senate and House of Representatives have different stances on e-cigarettes: the Senate advocates a ban on sales, while the House of Representatives proposes legalization and regulation
Recently, the Thai Senate and House of Representatives submitted research reports on e-cigarettes, but their positions were completely opposite. The report of the Senate Public Health Committee insisted on maintaining a complete ban on the import and sale of e-cigarettes, emphasizing the protection of public health, especially youth health, while the report of the House of Representatives Special Committee proposed to legalize e-cigarettes under a strict regulatory framework.
Sep.25 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Ministry of Health (Minzdrav) has expressed support for a full ban on vapes and “nalivayka” alcohol outlets, calling it an effective measure to curb harmful habits and improve public health.
Oct.17 by 2FIRSTS.ai
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
E-Cigarette Industry in Indonesia Expected to Create Up to 280,000 Jobs by 2030, Boosting Tax Revenue.
Sep.26 by 2FIRSTS.ai
Chill Brands acquires UK exclusive distribution rights for ELF nicotine pouches, also distributing ELFBAR and Lost Mary e-cigarettes
Chill Brands acquires UK exclusive distribution rights for ELF nicotine pouches, also distributing ELFBAR and Lost Mary e-cigarettes
Chill Brands Group has partnered with ELF Nicotine Pouches, appointing as its master distributor in the UK. Products will be distributed through the Chill Connect channel. All items are manufactured by Shenzhen iMiracle Technology, which also produces ELFBAR and Lost Mary e-cigarettes. The agreement covers distribution of ELF nicotine pouches, ELFBAR, and Lost Mary products across UK convenience stores.
Sep.11 by 2FIRSTS.ai